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Abstract
Background: Up to now, the feasibility and benefit of using fluorescein sodium 
under a dedicated surgical microscope filter (YE560, YELLOW 560 nm filter, Carl 
Zeiss Meditec, Germany) has never been clinically evaluated in infectious disorders 
of the brain. 
Case Description: Here, we report the case of a male patient with a brain 
abscess in the right parietal lobe that was removed under fluorescence-guidance 
(intravenous administration of fluorescein sodium 10%, 5 mg/kg bodyweight). The 
abscess capsule showed intensive yellow fluorescent staining, while − under white 
light − the cortex appeared normal.
Conclusion: This technique may improve the identification and surgical removal 
of brain abscesses. 
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INTRODUCTION
Fluorescein sodium (FL) has been increasingly used 
in oncologic neurosurgery, and its benefit has been 
repeatedly confirmed for high grade gliomas, brain 
metastases, and cerebral lymphomas.[7] Immediately 
after intravenous administration, FL accumulates 
in the disrupted blood–brain barrier (BBB) resulting 
in the dose‑dependent visualization of the area of 
increased vascular permeability. This effect can be 
intensified by the use of a dedicated light source and 
filter (“YE560,” YELLOW 560 nm Filter, Carl Zeiss 
Meditec, Oberkochen) integrated into the PENTERO 
900 surgical microscope (Carl Zeiss Meditec, 
Oberkochen).
However, to the best of our knowledge, the application 
of FL under the YE560 filter has never been evaluated 
for the visualization and removal of a brain abscess. 
Here, we report the rare case of a male patient with a 
brain abscess who was microsurgically treated with FL/
YE560.
CASE REPORT
A 45‑year‑old Caucasian male patient presented at our 
emergency department with headache, visual deficiencies, 
and moderate disorientation. On the day of the admission, 
he experienced a convulsive seizure. His medical history 
was free of any severe infections, immunomodulatory 
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diseases, severe traumas, malignancies, and recent surgical 
interventions. In the past years, he had not visited any 
tropical or subtropical areas.
Laboratory parameters on admission were not deranged 
and physical examination showed normothermia without 
meningeal irritation. In addition to the visual deficiencies 
and the mild mnestic impairment, no neurological 
deficits could be identified.
Immediate computed tomography (CT) scan showed 
a hypodense lesion in the right parietal region. On 
contrast‑enhanced magnetic resonance imaging (MRI), 
a ring‑shaped lesion in the right parietal lobe was 
noted [Figure 1a‑c]. The diffusion‑weighted images 
showed an intensive hyperintense signal, which was 
strongly suspicious for a brain abscess [Figure 1d].
Calculated antibiotic treatment was initiated with 
amoxicillin/clavulanic acid and metronidazole. The 
patient was prepared for surgical intervention. The 
patient was informed regarding the off‑label use of FL, 
and he provided written consent.
Approximately 30–45 minutes prior to skin incision, 
5 mg/kg bodyweight of FL (Natrium Fluoreszein® 10%, 
ALCON, Germany) was administered via the central 
venous line during induction of anesthesia.
Craniotomy was planned with neuronavigation. After 
durotomy, the PENTERO 900 surgical microscope was 
applied. The lesion could not be detected under white 
light, however, showed intensive fluorescent staining 
under the YE560 nm filter [Figure 2a and b]. After 
opening of the capsule, viscous pus poured out [Figure 3a] 
that was not fluorescing under filtered light [Figure 3b]. 
The pus and the capsule were microsurgically removed 
and sent to the neuropathology and microbiology 
department.
The postoperative course was uneventful. Because no 
microbiological specimen could be identified, calculated 
antibiotic treatment was continued. The visual 
deficiencies and the mnestic impairment completely 
resolved, and the patient was discharged after 5 weeks.
DISCUSSION
Many literature reports have described the feasibility 
and benefit of FL under the YE560 or in confocal 
laser‑endomicroscopy in malignant brain tumors.[2] 
In MRI contrast‑enhancing tumors, FL significantly 
enhances the extent of resection (EOR); thus, it is 
increasingly applied in neuro‑oncologic surgery. However, 
for neurosurgical purposes, FL is still off label because 
approval by most European authorities is still pending.
In high‑grade gliomas and cerebral metastases, the BBB is 
severely disrupted.[6] This condition is generally depicted 
by gadolinium, the contrast dye commonly used for 
contrast‑enhancement in T1‑weighted MR‑sequences. 
Similar to gadolinium, FL accumulates in the disrupted 
Figure 1:  (a‑c) Contrast‑enhanced T1‑weighted sequences show the brain abscess in the right parietal lobe; (d) diffusion‑weighted magnetic 
resonance imaging
dcba
Figure 2: (a, b) Surgical site after durotomy. No pathological 
alteration of the brain surface under white light (a), intense 
fluorescent staining under YE560 (b)
ba
Figure 3: (a, b) Surgical site after opening of the abscess. Drainage 
of pus under white light (a) and under YE560 (b). Note the 
nonfluorescence of the pus
ba
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BBB because of increased vascular permeability, 
warranting strong correspondence between radiographic 
contrast enhancement and intraoperative fluorescence.
The American surgeon George E. Moore pioneered 
FL‑guided surgery.[3] Even though he did not have 
first‑hand experience with FL in brain abscess surgery, 
he hypothesized “it can only be suggested that acute 
inflammatory tissue will probably take up a large 
amount of dye.“[4] In 1990, Nakagawa et al. evaluated 
FL in a rodent brain‑abscess model infected with 
Staphylococcus aureus and reported a clearly delineated 
fibrous capsule.[5] These results were confirmed 1 year 
later by Lo et al.[1] who described a marked breakdown 
of the BBB within 6 hours after inducing cerebritis with 
S. aureus in rats.
Many authors assumed that lesions with 
contrast‑enhancement in the T1‑weighted MR sequence 
excellently correspond to intraoperative fluorescence, 
irrespective of the biological and histological etiology of 
the lesion. For brain abscesses, however, this finding has 
only been confirmed experimentally but not clinically.
CONCLUSION
To the best of our knowledge, this is the first report 
evaluating the effect of FL under a dedicated microscope 
filter in a patient with a solid infectious lesion of 
the brain. In future, this technique can help identify 
subcortical or deeply located abscess formations and may 
be beneficial in increasing the rate of complete resection 
of abscess capsules. It is noteworthy that perilesional 
edema, to some degree is also stained yellow and must 
not be resected.
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